LanZhou Foci Pharmaceutical Co.,Ltd.

SZSE:002644.SZ

9.53 (CNY) • At close October 23, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 1,163.1341,019.176817.641668.051628.815544.581501.14363.255327.584399.071291.528266.362271.184262.406232.209219.012177.49
Cost of Revenue 801.839732.964594.494502.661461.623369.734352.086255.015244.927310.706187.658179.48177.99167.481144.171131.811104.86
Gross Profit 361.296286.212223.146165.39167.192174.847149.053108.2482.65888.366103.87186.88293.19494.92588.03887.20172.63
Gross Profit Ratio 0.3110.2810.2730.2480.2660.3210.2970.2980.2520.2210.3560.3260.3440.3620.3790.3980.409
Reseach & Development Expenses 30.92723.55619.35715.38320.64519.51717.39813.48510.00910.10510.9049.897.4644.5053.3132.5220
General & Administrative Expenses 19.11111.4279.5699.33112.5555.7314.3514.7144.8273.7064.7962.53.0553.0953.2613.5211.584
Selling & Marketing Expenses 153.728104.13881.26671.21291.22364.54145.04929.47225.79831.66335.82628.84331.03735.27634.88735.21724.03
SG&A 172.84115.56590.83680.543103.77870.27349.434.18730.62635.36940.62331.34234.09238.37138.14938.73835.613
Other Expenses -1.633-9.74724.36313.431-26.0880.3362.1596.2787.64310.9469.5146.914.75824.04513.5381.259-0.398
Operating Expenses 261.964129.373134.555109.35798.335112.82489.30974.11965.3267.50871.56755.48655.77557.4856.09656.70938.027
Operating Income 83.275139.401112.36264.43378.24286.14385.21764.68241.47128.43626.24227.60331.53231.66427.06724.94827.704
Operating Income Ratio 0.0720.1370.1370.0960.1240.1580.170.1780.1270.0710.090.1040.1160.1210.1170.1140.156
Total Other Income Expenses Net -1.633-12.404-1.54866.090.49124.45627.63136.46831.74818.4893.4513.115-1.12918.2648.663-4.285-7.296
Income Before Tax 81.642126.997110.814130.52378.73386.47987.37670.58949.08539.34735.75534.51136.29155.70940.60526.20727.306
Income Before Tax Ratio 0.070.1250.1360.1950.1250.1590.1740.1940.150.0990.1230.130.1340.2120.1750.120.154
Income Tax Expense 13.5221.06917.29622.8127.81113.5613.2839.6636.1384.6945.1594.1554.234.4674.4584.5983.994
Net Income 67.19108.65493.259108.01871.10772.91874.09360.92642.94834.65330.59630.35632.06151.24236.14721.60923.313
Net Income Ratio 0.0580.1070.1140.1620.1130.1340.1480.1680.1310.0870.1050.1140.1180.1950.1560.0990.131
EPS 0.130.210.180.210.150.140.150.120.0910.0970.0690.0680.0960.150.110.0660.069
EPS Diluted 0.130.210.180.210.150.140.150.120.0910.0970.0690.0680.0960.150.110.0660.069
EBITDA 151.908201.623144.603103.126141.229123.266111.90989.94466.80556.80659.19854.57248.03372.72257.92745.27637.365
EBITDA Ratio 0.1310.1980.1770.1540.2250.2260.2230.2480.2040.1420.2030.2050.1770.2770.2490.2070.211